Biofortuna to Use TriLink's CleanAmp dNTPs in PCR Kits

Biofortuna is developing unique HLA diagnostic kits that will address the transplantation, blood grouping, disease identification, and pharmacogenetic markets, with the first product line targeting the sequence-specific primer transplantation market.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories